Cargando…

Selenium and risk of bladder cancer

Detalles Bibliográficos
Autores principales:	Złowocka-Perłowska, E, Słojewski, M, Sikorski, A, Sukiennicki, G, Lubiński, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331841/ http://dx.doi.org/10.1186/1897-4287-10-S3-A23

Ejemplares similares

Selenium and gastrointestinal cancers risk
por: Lener, Marcin, et al.
Publicado: (2012)

Selenium and cancer risk in CHEK2 mutation carriers
por: Gupta, Satish, et al.
Publicado: (2012)

Selenium and the risk of cancers of the colon, pancreas and stomach
por: Lener, Marcin, et al.
Publicado: (2012)

Selenium (Se) and breast cancer risk
por: Jaworska - Bieniek, Katarzyna, et al.
Publicado: (2012)

Blood and serum samples collection and storage for further selenium measurements
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Selenium and genotypes as marker of risk in BRCA1 mutation carriers
por: Jaworska, K, et al.
Publicado: (2012)

Selenium (Se) and the risk of breast, ovarian and prostate cancers
por: Jaworska, Katarzyna, et al.
Publicado: (2012)

Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium
por: Jaworska, Katrzyna, et al.
Publicado: (2012)

Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

The influence of selenium concentration and variations in selenoprotein genes on the CHEK2-dependent cancers
por: Gupta, Satish, et al.
Publicado: (2015)

Survival of bladder or renal cancer in patients with CHEK2 mutations
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2021)

Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2021)

Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet
por: Lubiński, J, et al.
Publicado: (2012)

Selenium as diagnostic marker of cancers
por: Jaworska-Bieniek, Katarzyna, et al.
Publicado: (2015)

Selenium and the risk of cancer in BRCA1 carriers
por: Lubinski, J, et al.
Publicado: (2011)

Bladder cancer survival in patients with NOD2 or CDKN2A variants
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Arsenic (As) and breast cancer risk
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Iron and breast cancer risk
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Zinc and breast cancer risk
por: Kaczmarek, Katarzyna, et al.
Publicado: (2012)

Microelements as risk factors for cancer of the lung and larynx
por: Jaworska-Bieniek, Katrzyna, et al.
Publicado: (2012)

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Selenium and cancer prevention
por: Rayman, Margaret
Publicado: (2012)

Microelements as diagnostic markers of pancreatic cancer
por: Lener, Marcin, et al.
Publicado: (2015)

Serum selenium levels and the risk of progression of laryngeal cancer
por: Lubiński, Jan, et al.
Publicado: (2018)

Prospective clinical trials on correlations between macro-/ microelements and vitamins and cancer risk
por: Lubinski, Jan
Publicado: (2012)

Correction: Serum selenium levels and the risk of progression of laryngeal cancer
por: Lubiński, Jakub, et al.
Publicado: (2018)

Smoking Related Cancers and Loci at Chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish Population
por: Jaworowska, Ewa, et al.
Publicado: (2011)

Copper as diagnostic marker of cancers
por: Muszyńska, Magdalena, et al.
Publicado: (2015)

Magnesium as a diagnostic marker of cancer
por: Marciniak, Wojciech, et al.
Publicado: (2015)

Serum concentrations of Cu, Se, Fe and Zn in patients diagnosed with pancreatic cancer
por: Lener, Marcin, et al.
Publicado: (2015)

Zinc as diagnostic marker of cancers
por: Kaczmarek, Katarzyna, et al.
Publicado: (2015)

Iron as diagnostic marker of cancer
por: Sukiennicki, Grzegorz, et al.
Publicado: (2015)

Folic acid and breast cancer risk
por: Durda, Katarzyna, et al.
Publicado: (2012)

Prostate cancer screening based on genotyping for high risk founder alleles
por: Cybulski, Cezary, et al.
Publicado: (2012)

The effect of Selenium on thyroid physiology and pathology
por: Skowrońska-Jóźwiak, Elżbieta
Publicado: (2015)

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016
por: Cybulski, C., et al.
Publicado: (2017)

Diagnostic microarray test for a genetic predisposition to hereditary nonpolyposis colorectal cancer (HNPCC)
por: Kaszuba, M, et al.
Publicado: (2012)

Selenium and cancer – what have we learned from epidemiology and molecular epidemiology studies?
por: Jablonska, Ewa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6gt3r1p5np0ddjllk7d15t52nu